Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the …
…, JJ Vehreschild, MJGT Vehreschild… - The Lancet infectious …, 2019 - thelancet.com
Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality.
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical …
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical …
[HTML][HTML] Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis
…, OA Cornely, D Koehler, MJGT Vehreschild… - Clinical microbiology …, 2019 - Elsevier
Objectives Candidaemia is a serious hazard to hospitalized patients, but European
epidemiological data are restricted to national studies focusing on Northern Europe, population-…
epidemiological data are restricted to national studies focusing on Northern Europe, population-…
Mucormycosis treated with posaconazole: review of 96 case reports
JJ Vehreschild, A Birtel, MJGT Vehreschild… - Critical reviews in …, 2013 - Taylor & Francis
Mucormycosis is an emerging invasive fungal infection, primarily affecting immunocompromised
patients. The disease is difficult to diagnose and mortality reaches 40% even if treated …
patients. The disease is difficult to diagnose and mortality reaches 40% even if treated …
[HTML][HTML] Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
…, J Sinkó, A Skiada, MJGT Vehreschild… - Clinical Microbiology …, 2018 - Elsevier
The European Society for Clinical Microbiology and Infectious Diseases, the European
Confederation of Medical Mycology and the European Respiratory Society Joint Clinical …
Confederation of Medical Mycology and the European Respiratory Society Joint Clinical …
[HTML][HTML] European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in …
…, MH Wilcox, MJGT Vehreschild… - Clinical Microbiology …, 2021 - Elsevier
Scope In 2009, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
published the first treatment guidance document for Clostridioides difficile infection (CDI…
published the first treatment guidance document for Clostridioides difficile infection (CDI…
[HTML][HTML] Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China
…, M Eickmann, MJGT Vehreschild… - … England Journal of …, 2020 - Mass Medical Soc
Coronavirus in Travelers Returning from China A group of 126 German nationals was evacuated
from Wuhan to Frankfurt after screening for symptoms of Covid-19 and was to undergo …
from Wuhan to Frankfurt after screening for symptoms of Covid-19 and was to undergo …
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
…, R Santos, S Schwartz, JJ Vehreschild… - The Lancet infectious …, 2016 - thelancet.com
Background Mucormycosis is an uncommon invasive fungal disease with high mortality and
few treatment options. Isavuconazole is a triazole active in vitro and in animal models …
few treatment options. Isavuconazole is a triazole active in vitro and in animal models …
[HTML][HTML] Long-term cardiac pathology in individuals with mild initial COVID-19 illness
…, K Zacharowski, Y Khodamoradi, MJGT Vehreschild… - Nature medicine, 2022 - nature.com
Cardiac symptoms are increasingly recognized as late complications of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection in previously well individuals with mild …
syndrome coronavirus 2 (SARS-CoV-2) infection in previously well individuals with mild …
[PDF][PDF] Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients
The SARS-CoV-2 pandemic has unprecedented implications for public health, social life,
and the world economy. Because approved drugs and vaccines are limited or not available, …
and the world economy. Because approved drugs and vaccines are limited or not available, …
[PDF][PDF] Low-avidity CD4+ T cell responses to SARS-CoV-2 in unexposed individuals and humans with severe COVID-19
…, Y Khodamoradi, F Eberhardt, MJGT Vehreschild… - Immunity, 2020 - cell.com
CD4 + T cells reactive against SARS-CoV-2 can be found in unexposed individuals, and these
are suggested to arise in response to common cold coronavirus (CCCoV) infection. Here, …
are suggested to arise in response to common cold coronavirus (CCCoV) infection. Here, …